The Allurion Program is a weight loss platform that combines the Allurion Gastric Balloon, a swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite including ...
Stocktwits on MSN4d
Allurion Stock Tumbles Over Disappointing Quarterly Earnings, Revenue Guidance – But Retail’s Not ConcernedShares of Allurion Technologies, Inc. (ALUR) tumbled nearly 11% on Wednesday morning after the company’s fourth-quarter (Q4) ...
Allurion is dedicated to ending obesity. The Allurion Program is a weight loss platform that features the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-less™ intragastric ...
Reports Q4 revenue $5.6M, compared to $8.2M for the same period in 2023. The year-over-year decrease in revenue was primarily due to the ...
Second, the rapid weight loss achieved through the Allurion balloon the lifestyle modification strategies offered through the Allurion program. And the remote monitoring through the Allurion ...
Second, the rapid weight loss achieved through the Allurion Balloon, the lifestyle modification strategies offered through the Allurion program and the remote monitoring through the Allurion ...
Loss from Operations (Q4 2024): $17.1 million. Allurion Technologies Inc (NYSE:ALUR) reported a successful combination of their balloon program with low-dose GLP-1s, showing promising results in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback